Skip to main content

Table 1 Baseline clinical characteristics

From: Association between UCP2A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease

 

AA+AV (n= 383)

 

VV (n= 176)

  
  

Mean±SD

 

Mean±SD

p

Frequency (%)

68.5

 

31.5

  

Gender (man, %)

67.6

 

69.3

 

0.690

Age (y)

 

59.2±9.3

 

60.5±8.8

0.581

Hypertension (%)

56.7

 

62.5

 

0.193

Diabetes (%)

26.9

 

25.7

 

0.951

Glucose intolerance (%)

20.0

 

20.0

 

0.790

Normal Glucose Tolerance (%)

53.1

 

54.3

 

Dysglicemic (%)

46.9

 

45.7

 

High triglycerides (%)

55.8

 

58.6

 

0.537

LogTG*

 

2.2±0.2

 

2.2±0.2

0.308

Total Cholesterol (mg/dL)

 

222.0±48.3

 

224.8±47.2

0.522

LDL (mg/dL)

 

146.9±43.2

 

147.7±44.8

0.837

HDL (mg/dL)

 

37.4±10.5

 

37.4±10.6

0.961

Metabolic Sd (%)

51.2

 

47.3

 

0.462

Total Metabolic Sd

 

2.6±1.1

 

2.7±1.1

0.498

Obesity (%)

20.9

 

21.7

 

0.841

Double-vessel (%)

40.5

 

42.6

 

0.632

Multi-vessel (%)

59.5

 

57.4

 

Medical therapy (%)

32.4

 

33.0

 

0.935

PCI (%)

33.9

 

32.4

 

CABG (%)

33.7

 

34.7

 

Angina CCS 1 (%)

6.1

 

6.8

 

0.475

Angina CCS 2 (%)

64.0

 

58.2

 

Angina CCS 3 + 4 (%)

29.8

 

34.9

 

Current smoker (%)

31.6

 

29.0

 

0.534

AMI (inicial exams) (%)

45.4

 

44.9

 

0.904

  1. * Tryglicerides values were log transformed before comparison.
  2. PCI: percutaneous coronary intervention.
  3. CABG: coronary artery bypass surgery.
  4. CCS: Canadian Cardiovascular Society.
  5. AMI: acute myocardial infarction.